Overview
Status: Active
National Framework Of Qualifications (NFQ) Level: 9
NFQ Award Class: Major Award
Duration Part Time: 24 Month(s)
Total Credits: 90
Delivery Method: Blended
Connected Curriculum: - Employability
- Research Based Teaching
- Sustainability
Sustainable Development Goals (SDGs): - Decent Work and Economic Growth
- Responsible Consumption and Production
Graduate Attributes: - Creator, evaluator and communicator of knowledge
Work-Integrated Learning (Including Placement): No
The MEngSc in Pharmaceutical and Biopharmaceutical Engineering is a part-time programme that runs for a minimum of 24 months (maximum 60 months) from the date of first registration for the programme.
Exit Award - Postgraduate Diploma in Pharmaceutical and Biopharmaceutical Engineering
Students who achieve 40% in each individual taught module but fail to achieve the requisite grade of 50% across the taught modules, or students who pass all taught modules and do not wish to complete the Research Dissertation, may opt to exit the programme and graduate with a Postgraduate Diploma in Pharmaceutical and Biopharmaceutical Engineering.
Programme Requirements
For information about modules, module choice, options and credit weightings, please go to Programme Requirements.
Programme Requirements
Module List
| Code |
Title |
Credits |
| |
| |
| |
| PE6010 | Pharmaceutical Engineering | 5 |
| PE6011 | Biopharmaceutical Engineering | 5 |
| PE6013 | Powder and Particle Technology and Unit Operations | 5 |
| 15 |
| Introductory Pharmaceutical Chemistry (5) | |
| Biopharmaceutical Supporting Systems (5) | |
| Pharmaceutical Process Validation and Quality (5) | |
| Process Analytical Technology (5) | |
| |
| |
| PE6012 | Pharmaceutical Process Equipment, Materials and Mechanical Design | 5 |
| PE6016 | Process Optimisation and Scale-up in the Pharmaceutical Industry | 5 |
| PE6022 | Aseptic Manufacturing Design | 5 |
| PE6024 | Process Safety Engineering | 5 |
| PE6026 | Project Engineering - From Concept to Completion | 5 |
| PE6027 | Advanced Biopharmaceutical Engineering | 5 |
| |
| PE6021 | Dissertation in Pharmaceutical and Biopharmaceutical Engineering | 30 |
| Total Credits | 90 |
Examinations
Full details and regulations governing Examinations for each programme will be contained in the Marks and Standards Book and for each module in the Book of Modules.
Programme Learning Outcomes
Programme Learning Outcomes for MEngSc in Pharmaceutical and Biopharmaceutical Engineering (NFQ Level 9, Major Award)
On successful completion of this programme, students should be able to:
- Apply an enhanced knowledge and understanding of the mathematics, sciences, engineering sciences and technologies to pharmaceutical and biopharmaceutical engineering;
- Plan, research, execute and oversee a substantial research project, critically analyse and interpret data, and effectively disseminate the results;
- Identify, formulate, analyse and solve problems related to pharmaceutical and biopharmaceutical engineering;
- Design pharmaceutical and biopharmaceutical manufacturing facilities and processes, including unfamiliar, ill-defined scenarios, underpinned by a sustainability informed paradigm, taking account of environmental, health and safety and risk factors, and know how to apply relevant codes of practice, industry standards and emerging practices and technologies;
- Effectively design experiments and gather experimental data, apply a range of standard and specialized research tools and techniques and conduct critical evaluation of results;
- Reflect and act on social and ethical responsibilities in the practice of engineering, including the responsibilities towards developing sustainable processes and operations;
- Work effectively as an individual and in teams in planning and carrying through on assignments and projects in a lifelong learning context;
- Communicate effectively with the engineering community and with society at large.
